麻豆传媒

The American Gastroenterology Association (AGA) recommending antiviral drugs for patients at high risk for hepatitis B reactivation. (Gastroenterology)

Researchers identified the enzyme for therapies aiming to prevent metabolic dysfunction-associated steatotic liver disease (MASLD) from progressing to metabolic dysfunction-associated steatohepatitis (MASH). (Journal of Hepatology)

Meanwhile, modeling data predicted that by 2050 the in the U.S. population would increase from 34% to 41%, while the prevalence of MASH among adults would increase from 6% to 8%. (JAMA Network Open)

A single-center trial for hepatocellular carcinoma (HCC) surveillance in patients with cirrhosis. (Gastroenterology)

And for inflammatory bowel disease patients undergoing colorectal cancer (CRC) surveillance, how does high-definition, white-light endoscopy with segmental re-inspection compare with high-definition, dye-based chromoendoscopy? The weighed in. (Gut)

High costs are from getting colonoscopies. (The BMJ)

Compared with body mass index, measures of waist circumference and waist-to-hip ratio may better approximate the proportion of . (JAMA Network Open)

-- an indicator of pro- and anti-oxidants in an individual's diet -- negatively correlated with constipation in men and with diarrhea in women, U.S. data showed. (BMC Gastroenterology)

A combination of biomarkers could help . (Scientific Reports)

The FDA granted a breakthrough therapy designation for brelovitug, a monoclonal antibody in development for chronic hepatitis delta, drugmaker .

And the agency announced in combination with panitumumab (Vectibix) for adults with KRAS G12C-mutated metastatic CRC after specific chemotherapy regimens.

In other cancer news, the American Society of Clinical Oncology's Gastrointestinal Cancers Symposium kicked off on Thursday; check out 麻豆传媒's coverage here.

Comment